Hospital
Hudson Hospital, INC.
Hudson Hospital, INC. was paid $3.59M by Medicaid between Jan 2018 and Dec 2024, across 74 billing codes. Its largest line is 99284, emergency room visit (serious) — 20% of everything it billed.
33Billing provider infoHUDSON HOSPITAL, INC.
HUDSON, WI 54016
HUDSON, WI 54016
33aNPI1396849303assigned 09/11/2006
33bProvider typeCritical Access Hospital
28Total paid$3.59M
24GClaims86,892
24DCodes billed74
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Wisconsin
Rank by total paid#28 of 48
Median peer was paid$4.30M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,330 | $402K | |
| 2019 | 9,063 | $259K | |
| 2020 | 9,828 | $356K | |
| 2021 | 15,947 | $595K | |
| 2022 | 15,458 | $617K | |
| 2023 | 15,973 | $685K | |
| 2024incomplete | 11,293 | $680K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 5,804 | 4,529 | $712K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 4,510 | 3,825 | $695K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 4,095 | 3,141 | $577K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 8.4% | 1,551 | 301 | $301K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 7.5% | 1,224 | 740 | $269K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.3% | 2,044 | 1,737 | $264K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.9% | 877 | 766 | $212K |
| 96361 | Intravenous infusion, hydration; each additional hour | 5.8% | 572 | 441 | $209K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.9% | 1,340 | 1,171 | $69K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.5% | 246 | 197 | $54K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,724 | 3,025 | $35K |
| G0378 | Hospital observation service, per hour | <1% | 441 | 279 | $19K |
62 more codes
| 85027 | <1% | 4,161 | $16K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,051 | $15K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 789 | $14K |
| 81025 | <1% | 1,306 | $13K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,059 | $12K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 569 | $12K |
| 81001 | <1% | 2,978 | $10K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,992 | $10K |
| 84484 | <1% | 1,647 | $9K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,725 | $7K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 84 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,227 | $6K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 144 | $5K |
| 82248 | <1% | 1,734 | $4K | |
| 83690 | <1% | 824 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 490 | $3K |
| 84702 | <1% | 214 | $3K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 17 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,598 | $2K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 142 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,996 | $2K |
| 80076 | <1% | 322 | $2K | |
| 0012A | <1% | 60 | $2K | |
| 0011A | <1% | 96 | $2K | |
| 83735 | <1% | 413 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 238 | $1K |
| 83605 | <1% | 236 | $1K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,880 | $908.82 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,732 | $857.96 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 71 | $756.19 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,834 | $733.44 |
| 0240U | <1% | 45 | $608.56 | |
| 85610 | <1% | 206 | $600.87 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 65 | $576.28 |
| 85379 | <1% | 110 | $573.87 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 13 | $507.20 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,451 | $451.21 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 12 | $393.18 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,498 | $363.37 |
| 82947 | <1% | 89 | $300.96 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,865 | $284.90 |
| 71045 | Radiologic examination, chest; single view | <1% | 454 | $284.82 |
| 82077 | <1% | 26 | $248.76 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,304 | $236.32 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 113 | $207.89 |
| 86140 | <1% | 70 | $194.69 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,143 | $180.25 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,708 | $172.21 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 12 | $168.60 |
| 87040 | <1% | 44 | $159.90 | |
| 82962 | <1% | 44 | $112.40 | |
| 81003 | <1% | 18 | $82.92 | |
| 86901 | <1% | 15 | $55.63 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 262 | $44.69 |
| 99152 | <1% | 17 | $2.75 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 17 | $1.79 |
| A9270 | Non-covered item or service | <1% | 2,959 | $0.14 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 1,089 | $0.03 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 18 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 118 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 35 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSON, DOUGLAS (CFO)
| Provider | Location | Paid |
|---|---|---|
| Westfields Hospital, INC. | New Richmond, WI | $8.53M |
| Lakeview Memorial Hospital Association INC | Stillwater, MN | $3.11M |
| Sports & Wellness Physical Therapy, INC. | San Luis Obispo, CA | $655K |
| Douglas W Johnson, MD, INC | Honolulu, HI | $367K |
| Lakeview Memorial Hospital Association INC. | Stillwater, MN | $365K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.